BioSpace News Archive

Business

Aglaris Appoints New CEO to Drive Commercialisation of Ground-breaking Cell-based Therapy Manufacturing System

Aglaris Ltd. today announced the appointment of Steven Docksey to the role of CEO of the Anglo-Spanish cell therapy equipment manufacturer, effective immediately.

October 9, 2018
·
3 min read
Business

Calithera Biosciences Announces Clinical Trial Collaboration to Evaluate IBRANCE® (palbociclib) and talazoparib in Combination with CB-839

Phase 1/2 trials expected to initiate 1Q2019

October 9, 2018
·
5 min read
BioCapital

CureSearch for Children’s Cancer Announces Research Award Opportunities

Up to $7 million in research awards will accelerate the development of better, less-toxic children’s cancer treatments

October 9, 2018
·
1 min read
Policy

U.S. Food and Drug Administration Accepts Karyopharm’s New Drug Application for Selinexor and Grants Priority Review

Application Seeks Accelerated Approval for Selinexor as a Treatment for Patients with Penta-Refractory Multiple Myeloma

October 9, 2018
·
17 min read
Policy

ACACIA PHARMA PROVIDES UPDATE ON FDA REGULATORY REVIEW OF BARHEMSYS™

FDA issued a Complete Response letter to Acacia Pharma on Friday 5 October

October 9, 2018
·
4 min read
New biopharmaceutical company Sitryx launches with $30 million fundraising to develop disease modifying therapeutics in immunometabolism

Fast-emerging area of research with potential to treat severe diseases including cancer and autoimmune conditions

October 9, 2018
·
5 min read
Business

eTheRNA opens state-of-the-art manufacturing facility in Belgium to support the development of its TriMix-based mRNA cancer immunotherapies

eTheRNA immunotherapies announces the opening of a state-of-the-art mRNA manufacturing facility enabling the production of mRNA immunotherapies.

October 9, 2018
·
4 min read
FDA

Four Life Science Companies Make Time’s Genius List

In looking at companies that are shaping the future, Time Magazine selected 50 business that are leading the charge. While many tech companies lead the way, there are several pharma and life science companies that are also disrupting the future.

October 9, 2018
·
2 min read
·
Alex Keown
The Importance of Diversity in Clinical Trials (Because Right Now, It’s Lacking)

Although race is thought of as a social concept, ‘there’s growing evidence that, whether for environmental or genetic reasons, drugs may have different effects on different populations.’

October 9, 2018
·
6 min read
·
Chelsea Weidman Burke
Bio NC

EpiCypher SNAP-ChIP® technology poised to transform market for histone PTM antibodies

A recently published report in Molecular Cell validates the use of EpiCypher’s proprietary SNAP-ChIP® technology for profiling antibody specificity and sensitivity.

October 9, 2018
·
1 min read